About this trial
The study focuses on evaluating the effectiveness and safety of tubeless anesthesia in single-port thoracoscopic surgery for early-stage lung cancer patients. Traditional anesthesia methods risk postoperative complications like lung injury and respiratory issues. Tubeless anesthesia preserves spontaneous breathing without tracheal intubation, potentially reducing these complications and enhancing recovery. The study aims to compare this technique with traditional methods, assessing its impact on contralateral lung complications, perioperative hemodynamics, complication rates, and recovery speed.
Eligibility criteria
Qualifiers
Age ≥18 years and ≤70 years;
ECOG performance status score 0-1;
Good cardiac and pulmonary function;
Single or multiple peripheral lung nodules planned for single-port thoracoscopic surgery, with or without mediastinal lymph node dissection or sampling;
Disqualifiers
Obese patients (BMI >30);
Patients with difficult intubation or expected complex airway management;
COPD patients with copious airway secretions;
Patients with neurological dysfunction or who cannot cooperate while awake;
Trial design
Treatments tested in this trial
- Tubeless anesthesia
- Traditional tracheal intubation